Why is Sundaram Multi Pap Ltd falling/rising?

Recent Price Movement and Market Performance

On 02-Mar, Sundaram Multi Pap Ltd’s share price closed at ₹1.39, down by ₹0.13 or 8.55% from the previous session. This decline marks the stock’s new 52-week low of ₹1.35, reflecting ongoing bearish sentiment. The stock has been falling for two consecutive days, losing 12.34% over this short period. This recent weakness is more pronounced than the broader Printing & Stationery sector, which itself declined by 3.66% on the same day, indicating that Sundaram Multi Pap is underperforming its peers.

The stock’s underperformance extends beyond daily fluctuations. Over the past week, it has dropped 13.13%, significantly worse than the Sensex’s 3.67% decline. The trend continues over longer periods, with the stock falling 12.03% in one month and 22.78% year-to-date, while the Sensex has only declined 1.75% and 5.85% respectively in these intervals. Over the past year, Sundaram Multi Pap’s stock has plummeted 31.86%, contrasting sharply with the Sensex’s 9.62% gain. This persistent underperformance highlights investor concerns about the company’s prospects.

Technical Indicators and Trading Activity

Technically, the stock is trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning typically signals a bearish trend and may discourage short-term traders from entering long positions. However, there has been a notable increase in investor participation, with delivery volumes rising by 35.37% on 27 Feb compared to the five-day average. This suggests that while the stock is falling, some investors may be accumulating shares at lower prices, possibly anticipating a turnaround.

Financial Performance: Positive Quarterly Results Amidst Long-Term Challenges

Despite the recent share price weakness, Sundaram Multi Pap Ltd reported encouraging quarterly results in December 2025. Net sales grew by 22.05% to ₹26.07 crores, while operating profit to net sales ratio reached a quarterly high of 8.06%. The company also posted its highest quarterly profit after tax (PAT) of ₹1.45 crores. These results mark two consecutive quarters of positive financial performance, which could be viewed favourably by investors seeking growth signals.

However, these short-term gains are tempered by the company’s weak long-term fundamentals. The average return on capital employed (ROCE) stands at a low 1.94%, indicating limited efficiency in generating returns from invested capital. Operating profit growth over the past five years has been modest at an annual rate of 13.96%, which may not be sufficient to inspire confidence in sustained expansion. Furthermore, the company’s ability to service debt is concerning, with an average EBIT to interest coverage ratio of just 0.40, signalling potential financial strain.

Valuation and Risk Considerations

Sundaram Multi Pap Ltd’s stock is considered risky relative to its historical valuations. Over the past year, the stock has delivered a negative return of 31.86%, despite profits rising by 146.9%. This disparity results in a price-to-earnings-growth (PEG) ratio of 0.6, which may suggest undervaluation but also reflects market scepticism about the sustainability of profit growth. The stock’s consistent underperformance against the BSE500 benchmark over the last three years further underscores investor caution.

Majority shareholding by non-institutional investors may also contribute to volatility, as institutional backing often provides stability and confidence in a company’s governance and prospects.

Conclusion: Why the Stock Is Falling

In summary, Sundaram Multi Pap Ltd’s share price decline as of 02-Mar is driven by a combination of factors. While the company has demonstrated positive quarterly sales and profit growth, these gains are overshadowed by weak long-term financial metrics, poor debt servicing capacity, and consistent underperformance relative to market benchmarks. The stock’s technical weakness, reflected in trading below all major moving averages and hitting a new 52-week low, further exacerbates investor concerns. Although rising delivery volumes indicate some buying interest, the prevailing sentiment remains cautious, resulting in continued downward pressure on the stock price.

Investors should weigh the company’s recent operational improvements against its fundamental challenges and market performance before considering exposure to Sundaram Multi Pap Ltd.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →